Company / Current Liabilities per Share
Amphstar Pharmaceuticals, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$3.32
FY2025
5-year range
$1.99 / $4.69
FY2021-FY2025
Trend
-8.1%
vs FY2024
Sector context
#50 of 210
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s current liabilities per share of $3.32 is higher than 76% of companies in the Health Care sector (FY2025). Current Liabilities per Share has fluctuated over the past 10 years, ranging from $1.34 in FY2016 to $4.69 in FY2023.
Based on SEC 10-K filings.
3.32 in FY2025 with a 5-year CAGR of +6.6%. Top quartile in the Health Care sector.
Improved from $4.69 to $3.32 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +18.7%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Sector benchmark
-86.0% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 8.1% year-over-year.
- Ranks #50 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.32 | -8.1% |
| FY2024 | $3.61 | -22.8% |
| FY2023 | $4.69 | +135.7% |
| FY2022 | $1.99 | -9.0% |
| FY2021 | $2.19 | -9.3% |
| FY2020 | $2.41 | +24.8% |
| FY2019 | $1.93 | -15.8% |
| FY2018 | $2.29 | +57.7% |
| FY2017 | $1.45 | +8.3% |
| FY2016 | $1.34 | -0.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026